Dr Reddy's Laboratories Limited Unit 1
- PharmAssess™ GMP Audit
About Dr Reddy's Laboratories Limited
Headquartered in India, Dr Reddy’s is a global, vertically integrated pharmaceutical company with a presence across the value chain, producing and delivering safe, innovative, and high quality finished dosage forms, APIs and biological products.
Their products are marketed across the globe, with an emphasis on North America, Europe, India, Russia and other emerging markets. Dr Reddy's conduct NCE drug discovery research in the areas of metabolic disorders and cardiovascular indications at our research facilities in Atlanta (USA) and Hyderabad (India).
Through their Custom Pharmaceutical Services business unit, they provide drug substance and drug product development and manufacturing services on a proprietary basis.
Dr Reddys Laboratories Limited Unit 1, manufactures a number of APIs, including Cetirizine dihydrochloride, Losartan potassium and Clopidogrel bisulphate.
About the Audit
The audit of Dr Reddys Laboratories Limited Unit 1 site was performed on 29 - 30 January 2008. The Report includes photographs and is 30 pages long, excluding appendices. Including appendices, the Report is 62 pages long.
The Audit Report provides information on the site facilities and covers a wide range of materials, including; Cetirizine Di Hydrochloride, Clopidogrel Bisulfate (Form 1), Fexofenadine Hydrochloride (Form X), Fluoxetine Hydrochloride, Lamotrigine, Levitiracetam, Losartan Potassium (Form 1), Meolxicam, Norfloxacin, Risperidone (Form 1), Risperidone (Mixed), Rivastigimine Hydrogen Tartrate, Ziprasidone Hydrochloride, Ziprasidone Hydrochloride Monohydrate, Losartan Potassium, Candesartan Cilexetil, Zolmitriptan, and Alfuzocin Hydrochloride.
How to Purchase an Audit
Once you have decided which PharmAssess™ audit report(s) you require, purchasing a report is very simple:
- A quotation will be sent to you for the purchase of the Audit Report(s) you require.
- Rephine obtains auditee's approval for sale of the report.
- Once approval of the Quotation is received we will dispatch the Audit Report, in CD format accompanied by an Invoice.
- On receipt of payment the password to access the report is immediately issued
Purchase this Audit »
Ad-Hoc Audit Requirements
Please note that if there are other audits that you require, which are not in the PharmAssess Section of this website, please contact us to discuss your audit requirements, which we can undertake on your behalf.
Rephine has an ongoing programme of audits which is being constantly updated. If an audit you require is not on the list of those available, please contact the Rephine office to establish whether it is in the programme to be done or how it can be fitted in to the programme.
Commissioned GMP Auditing »
Further Information
If you require further information about the PharmAssess™ services offered by Rephine, or you would like to purchase an Audit Report, please contact us by email at enquiries@rephine.com or telephone 0044 1763 853135